Transgastrostomal Endoscopies

December 9, 2020 updated by: Yale University

Efficacy of Transgastrostomal Esophagogastroduodenoscopies in Children

Upper GI endoscopies are commonly done by inserting the endoscope through the patient's mouth. When a patient has a gastrostomy feeding tube, the endoscope can be inserted through the stomach port opening. The aim is to prove this modification would lead to various health benefits, including need for lighter anesthesia, rapid recovery time and fewer anesthesia related adverse reactions.

Study Overview

Status

Withdrawn

Detailed Description

Pediatric esophagogastroduodenoscopies (EGD) are commonly used for diagnosis and treatment of various GI conditions. Appropriate sedation or anesthesia and analgesia is critical for enhancing the effectiveness and feasibility of EGD. General anesthesia or deep sedation are commonly used for this procedure. Midazolam is the most common intravenous sedative in use, often in combination with ketamine, propofol, meperidine or fentanyl.

Despite technical advances in patient monitoring and the safety of anesthesia and sedation drugs, procedural anesthesia or sedation adverse events may occur. Desaturation during the procedure is the most common adverse event, followed by vomiting, excessive secretion and unexpected apnea. Children with aero-digestive pathologies and feeding disorders often carry significant underlying co-morbidities, increasing their anesthesia risk. Previous studies have shown that caution must be exercised in children with potential airway problems or uncorrected cardiopulmonary anomalies such as laryngomalacia, chromosomal abnormalities, tetralogy of fallot and bronchopulmonary dysplasia. In addition, this population is often at increased risk for concurrent respiratory conditions, which may increase the risk for laryngospasm during the procedure.

As the endoscope is inserted transorally, it may also be an important trigger for laryngospasm. Alternatives to oral insertion of the endoscope have been described and shown to be more beneficial than the oral route in some patients. For example, previous studies have shown that transnasal endoscopies are known to be less of a burden to patients, and have benefits including fewer effects on respiratory and cardiovascular status and reduced recovery time after procedure.

Alternatively, insertion of the endoscope through the gastrocutaneous tract is possible among patients with a percutaneous gastrostomy feeding tube. This technique has been well described in the adult population for observation, diagnosis and treatment of various digestive diseases. As children with aero-digestive and feeding disorders often have a percutaneous gastrostomy feeding tube, and are at increased risk for anesthesia adverse events, transgastrostomal endoscopies me be beneficial in this patient population. To date, this method has not been reported and examined in children undergoing EGDs.

The aims of this study:

  1. Examine the feasibility of transgastrostomal EGDs in children Assess the ability to explore the upper GI tract from proximal esophagus to the second part of the duodenum and obtain adequate tissue biopsies.
  2. Assess the need for anesthesia and sedation In the adult population transgastrostomal endoscopies are done with no anesthesia or sedation. Previous studies on adult population have shown that even with lack of sedation, this procedure was not associated with any decrease of oxygen saturation nor a significant difference in fluctuations of blood pressures and heart rate in comparison to oral EGDs. As for children, a "lighter" anesthesia with inhalation with a face mask or sedation with intranasal application of dexmedetomidine hydrochloride may provide adequate anesthesia or sedation for this procedure. However, the decision regarding the type of anesthesia used during endoscopy remains per anesthesiologist discretion and is not part of this study.
  3. Examine the benefits of this procedure in comparison to oral EGD Specifically, will examine the rate of procedural sedation or anesthesia adverse events and patients' recovery time.

4. Research Plan:

Study will take place at the children's operating room of Yale New Haven Hospital.

Enrollment to the study will take place on the day of the endoscopy during the pre-procedural assessment. Eligible patients will be offered to have a transgastrostomal endoscopy instead of a transoral one.

Similar to a transoral EGD, on the patient's arrival to the operating room (OR) the anesthesia team will obtain vital signs (blood pressure, heart rate, respiratory rate and oxygen saturation). Those would be monitored continuously during the procedure.

Once the preprocedural assessment is completed, the anesthesiologist will determine the type of anesthesia: intravenous drugs, gas inhalation or intranasal dexmedetomidine hydrochloride at a standard dosage of 2 mcg/kg. As "lighter" anesthesia may be used in this study (compared to transoral EGDs), the depth of anesthesia will be continuously monitored. The patients will be connected to a bispectral index (BIS) monitor, which identifies changes in electrophysiologic brain activity during general anesthesia. The BIS monitor, derived from electroencephalogram (EEG) data, has been shown to be a useful cerebral monitor of anesthesia depth.

Once the patient is laid in the supine position, the gastrostomy tube is removed. After applying a lubricant around the endoscope, it is inserted through the fistural tract and advanced into the gastric lumen. At this point a standard endoscopy will be conducted (with no significant changes compared to a transoral EGD). The endoscope is directed to the oral side and advanced to the esophagogastric junction. The endoscope is retrogradely inserted through the esophagus, and proximal and distal esophageal biopsies are obtained. The endoscope is then withdrawn to the stomach and directed to the anal side. The endoscope is inserted up to the second part of the duodenum from the stoma. Duodenal biopsies are obtained from the 2nd duodenal part and the duodenal bulb. The endoscope is pulled back to the stomach and turned back to look around the stoma. Gastric biopsies are obtained from the body of the stomach and the pre-pyloric region. After observation of the upper gastrointestinal tract, air is suctioned and the endoscope is withdrawn from the stoma. The gastrostomy tube is placed.

Procedure length is estimated at 15 minutes.

The main differences between a standard transoral endoscopy and a trandgastrotsotmal one are:

  1. Insertion of the endoscope through the G-tube port and not the mouth.
  2. The need to remove the existing G-tube and replace it once the endoscopy is done
  3. Potential use of "lighter" sedation. In this study the depth of anesthesia will be monitored with a BIS monitor. This monitor is not used during a standard EGD.

The procedure's efficacy, length and adverse reaction will be compared to the standard transoral endoscopy.

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Connecticut
      • New Haven, Connecticut, United States, 06520
        • Yale University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 month to 18 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

- children with a percutaneous gastrostomy feeding tube, who are about to have a diagnostic esophagogastroduodenoscopy.

Exclusion Criteria:

  • age>18 years,
  • G-tube size <12Fr.
  • Patients with immature gastrocutaneous fistula (< 4 weeks after gastrostomy)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: G-tube endoscopies patients
patients who will undergo an endoscopy through g-tube port
Placement the endoscope through the g-tube port and not through the mouth of a patient undergoing an upper gi endoscopy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Obtain adequate biopsies
Time Frame: 15 minutes
Conduct a full endoscopy via g-tube port. Advance the scope to all standard locations including proximal esophagus, distal esophagus, stomach, duodenal bulb and the second part of the duodenum. Obtain at least 2 specimens from each location.
15 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
anesthesia related adverse reactions
Time Frame: 15 minutes
Assess the rate of anesthesia related adverse reactions. Specifically, record the number of oxygen desaturations during the endoscopy (vital signs are continuously recorded during the exam). After the procedure the anesthesia team will summarize any anesthesia adverse reactions that have occurred during the exam.
15 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

December 1, 2021

Primary Completion (Anticipated)

April 1, 2025

Study Completion (Anticipated)

April 1, 2025

Study Registration Dates

First Submitted

March 12, 2020

First Submitted That Met QC Criteria

March 12, 2020

First Posted (Actual)

March 16, 2020

Study Record Updates

Last Update Posted (Actual)

December 11, 2020

Last Update Submitted That Met QC Criteria

December 9, 2020

Last Verified

December 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 2000027348

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on transgastrostomal endoscopy

Subscribe